Entering text into the input field will update the search result below

Carlyle to buy J&J's diagnostics unit for $4.15B

Jan. 16, 2014 8:01 AM ETThe Carlyle Group Inc. (CG) StockBy: Yigal Grayeff, SA News Editor1 Comment
  • Carlyle (NASDAQ:CG) confirms that it has agreed to acquire Johnson & Johnson's (JNJ +0.3%) Ortho-Clinical Diagnostics (OCD) business for $4.15B.
  • "This transaction is a result of our disciplined approach to portfolio management in order to achieve the greatest value for Johnson & Johnson," J&J CEO Alex Gorsky says.
  • OCD provides products for screening, diagnosing, monitoring and confirming diseases, including blood-screening equipment and laboratory blood tests. It's a smallish player in a market led by Roche, Siemens and Abbott Labs. (PR)

This was corrected on 06/07/2022 at 9:33 AM. Carlyle's ticker was incorrect.

Recommended For You

About CG Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CG--
The Carlyle Group Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.